THOMAS SCIASCIA
CIK 1229946 · Chief Scientific Officer · last filed 2026-02-20
THOMAS SCIASCIA is a Chief Scientific Officer who has filed 29 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for TRVI, was dated Feb 20, 2026. Across all open-market trades the lifetime net is −$289.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.06M
2
29
-$289.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRVI | Chief Scientific Officer | 221,373 | $18.36 | $4.06M | -$289.6K | 18 | 2026-02-20 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | SVP Clin Dev & Reg Aff & CMO | 0 | — | — | $0 | 8 | 2010-09-22 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-20 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-03-26 | TRVI | Mixed | — | -$13.6K | EDGAR |
| 2025-03-12 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-02-20 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2024-08-21 | TRVI | Mixed | — | -$25.3K | EDGAR |
| 2024-08-16 | TRVI | Mixed | — | -$42.2K | EDGAR |
| 2024-08-15 | TRVI | Notice (144/A) | −48,001 | -$125.3K | EDGAR |
| 2024-08-15 | TRVI | Notice (144) | −48,001 | -$125.3K | EDGAR |
| 2024-05-31 | TRVI | Mixed | +5,986 | -$6.1K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.